Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE.
about
Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application.Association between ambient temperature and blood pressure and blood pressure regulators: 1831 hypertensive patients followed up for three years.Reduced cardiorespiratory fitness after stroke: biological consequences and exercise-induced adaptations.Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibitionRole of TNF-alpha in vascular dysfunction.Acute heart failure as "acute endothelitis"--Interaction of fluid overload and endothelial dysfunction.Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: the ramipril C-reactive pRotein randomized evaluation (4R) trial resultsInduction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis.Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.Systemic inflammation and endothelial dysfunction in dogs with congestive heart failure.Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)
P2860
Q33504342-5511E901-7100-4AF5-8BFF-34CB9B4865F8Q35082998-A8D99526-37FB-4AED-8404-605C92A4492CQ35174397-8E25C74A-D1D2-42EE-BB53-4F889124D88DQ36968558-1ACAC4C8-6224-4289-9AF0-0E41B92B10D7Q37050343-77C5BF25-013D-4553-9C31-15D1461C1AA9Q37086304-9AA0AA25-EAE8-4402-A0BF-E5157B763D97Q37295193-F2A72AE3-687D-4373-9B4C-6E20E3E58962Q37588140-EEC6E640-4650-4CED-AC8C-536409E03A7BQ38007893-2EA81B8D-1E2A-4718-A518-952785C896D9Q46151507-B3CF49F4-47A7-4E2C-8B79-F4B0600E8BFAQ48576177-33CB74D4-AB8C-45F5-8513-A2E4697A9953Q57616342-93C08EF9-20D4-460D-A395-74B12A0A1745
P2860
Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Correlation of flow mediated d ...... effects of inhibition of ACE.
@en
Correlation of flow mediated d ...... effects of inhibition of ACE.
@nl
type
label
Correlation of flow mediated d ...... effects of inhibition of ACE.
@en
Correlation of flow mediated d ...... effects of inhibition of ACE.
@nl
prefLabel
Correlation of flow mediated d ...... effects of inhibition of ACE.
@en
Correlation of flow mediated d ...... effects of inhibition of ACE.
@nl
P2093
P2860
P1476
Correlation of flow mediated d ...... effects of inhibition of ACE.
@en
P2093
Akos Koller
Imre Kovacs
Janos Toth
Jeno Tarjan
P2860
P304
P356
10.1016/J.EJHEART.2005.10.011
P577
2005-12-01T00:00:00Z